Mario Gabelli Danaher Corp Transaction History

Gamco Investors, Inc. Et Al

$9.3 Billion
Q2 2025

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Danaher Corp stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 1,600 shares of DHR stock, worth $329,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,600

Previous 1,610 0.62%

Holding current value

$329,152

Previous $330,000 4.24%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$174.64 - $205.16 $1,746 - $2,051	-10 Reduced 0.62%	1,600 $316,000
Q1 2025 May 14, 2025	SELL	$201.62 - $250.59 $203,837 - $253,346	-1,011 Reduced 38.57%	1,610 $330,000
Q4 2024 Feb 13, 2025	SELL	$226.16 - $274.52 $112,175 - $136,161	-496 Reduced 15.91%	2,621 $601,000
Q3 2024 Nov 14, 2024	BUY	$239.25 - $280.76 $210,779 - $247,349	881 Added 39.4%	3,117 $866,000
Q2 2024 Aug 13, 2024	SELL	$235.51 - $267.98 $219,495 - $249,757	-932 Reduced 29.42%	2,236 $558,000
Q1 2024 May 14, 2024	SELL	$224.58 - $256.19 $2.35 Million - $2.69 Million	-10,485 Reduced 76.8%	3,168 $791,000
Q3 2023 Nov 08, 2023	SELL	$233.08 - $265.59 $926,959 - $1.06 Million	-3,977 Reduced 22.56%	13,653 $3.39 Million
Q2 2023 Aug 10, 2023	BUY	$224.99 - $256.14 $58,272 - $66,340	259 Added 1.49%	17,630 $4.23 Million
Q1 2023 May 12, 2023	BUY	$239.75 - $277.0 $52,984 - $61,217	221 Added 1.29%	17,371 $4.38 Million
Q4 2022 Feb 13, 2023	SELL	$241.42 - $282.29 $1.04 Million - $1.21 Million	-4,290 Reduced 20.01%	17,150 $4.55 Million
Q3 2022 Nov 10, 2022	BUY	$247.06 - $1507.4 $83,012 - $506,486	336 Added 1.59%	21,440 $5.54 Million
Q2 2022 Aug 12, 2022	SELL	$237.11 - $299.66 $31,061 - $39,255	-131 Reduced 0.62%	21,104 $5.35 Million
Q1 2022 May 13, 2022	BUY	$257.27 - $315.76 $48,109 - $59,047	187 Added 0.89%	21,235 $6.23 Million
Q4 2021 Feb 11, 2022	BUY	$292.08 - $329.01 $11,099 - $12,502	38 Added 0.18%	21,048 $6.93 Million
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $21,776 - $26,594	-80 Reduced 0.38%	21,010 $6.4 Million
Q2 2021 Aug 13, 2021	BUY	$225.08 - $271.69 $313,086 - $377,920	1,391 Added 7.06%	21,090 $5.66 Million
Q1 2021 May 14, 2021	BUY	$212.38 - $245.9 $105,765 - $122,458	498 Added 2.59%	19,699 $4.43 Million
Q4 2020 Feb 05, 2021	SELL	$212.5 - $245.46 $342,125 - $395,190	-1,610 Reduced 7.74%	19,201 $4.27 Million
Q3 2020 Nov 06, 2020	BUY	$177.16 - $215.33 $491,796 - $597,756	2,776 Added 15.39%	20,811 $4.48 Million
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $186,486 - $256,226	1,449 Added 8.74%	18,035 $3.19 Million
Q1 2020 May 14, 2020	BUY	$121.39 - $169.05 $214,617 - $298,880	1,768 Added 11.93%	16,586 $2.3 Million
Q4 2019 Feb 14, 2020	BUY	$133.47 - $153.48 $699,115 - $803,928	5,238 Added 54.68%	14,818 $2.27 Million
Q3 2019 Nov 01, 2019	BUY	$135.4 - $146.47 $31,548 - $34,127	233 Added 2.49%	9,580 $1.38 Million
Q2 2019 Aug 02, 2019	BUY	$124.88 - $143.73 $7,492 - $8,623	60 Added 0.65%	9,347 $1.34 Million
Q1 2019 May 02, 2019	SELL	$97.62 - $132.29 $6,150 - $8,334	-63 Reduced 0.67%	9,287 $1.23 Million
Q4 2018 Jan 30, 2019	BUY	$94.85 - $109.54 $14,227 - $16,431	150 Added 1.63%	9,350 $964,000
Q3 2018 Nov 02, 2018	SELL	$98.13 - $108.9 $6,869 - $7,623	-70 Reduced 0.76%	9,200 $1 Million
Q2 2018 Aug 10, 2018	SELL	$96.1 - $103.24 $61,504 - $66,073	-640 Reduced 6.46%	9,270 $915,000
Q1 2018 May 09, 2018	SELL	$92.16 - $103.8 $5,068 - $5,709	-55 Reduced 0.55%	9,910 $970,000
Q4 2017 Feb 02, 2018	SELL	$85.26 - $94.62 $28,988 - $32,170	-340 Reduced 3.3%	9,965 $925,000
Q3 2017 Nov 01, 2017	BUY	$79.29 - $88.45 $817,083 - $911,477	10,305	10,305 $884,000

Others Institutions Holding DHR

# of Institutions

2,489

Shares Held

570M

Call Options Held

6.87M

Put Options Held

3.36M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $150B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account